Blog Archives

Now is the time for transparency and access to clinical-trial data

Category: Access | Tagged , , , , , , , , , | Leave a comment

Book Review: What can we do about ‘Bad Pharma’?

Category: Book Review, General | Tagged , , , , , | Leave a comment

Beyond the Donor Years: Time for Co-Development in Global Health

Category: General | Tagged , , , , , | Leave a comment

This Week in PLOS Medicine: Type 1 diabetes; Obesity & malnutrition; Remote health care; GMHP

Category: PLoS Medicine Week by Week | Tagged , , , , , | Leave a comment

India’s patent law on trial

Category: General | Tagged , , , , | Leave a comment

Why the United States Needs Better Confidentiality Laws for Minors with HIV/AIDS

Category: AIDS2012, General | Tagged , , , , , , | Leave a comment

Is it time to start evaluating social policy using randomised trials?

Category: General, Policy | Tagged , , | Leave a comment

Do No Harm: How a US-Led Free Trade Agreement Threatens the Prospects for an AIDS-Free Generation

Category: AIDS2012 | Tagged , , , , , , , , , , | Leave a comment

Have management papers ever changed practice in healthcare?

Category: General | Tagged , , | Leave a comment

This Week in PLoS Medicine: Co-proxamol deaths; Aid & govt spending; HIV & TB in prisons

Category: PLoS Medicine Week by Week | Tagged , , , , , , , , , , , , , | Leave a comment